The health and life sciences sector is one of the most heavily regulated and technically complex in the legal landscape: pharmaceutical companies, medical device manufacturers, hospitals, laboratories, specialized distributors, and new players in digital health operate within demanding frameworks that combine health regulations, intellectual property laws, product regulations, sensitive data protection, and unique commercial dynamics. Central America is a strategic region for the sector: Costa Rica serves as a regional hub for medical device manufacturing, several countries function as entry points for international pharmaceutical products, and digitalization is opening up new frontiers in telemedicine, digital health, and clinical data management.

We advise international pharmaceutical companies, medical device manufacturers, private hospitals, and emerging digital health players, and this diversity of clients allows us to integrate health regulations with intellectual property, commercial regulations, and data protection. We are familiar with the distinct regulatory frameworks of each country which enables us to support regional operations with predictability on a jurisdiction-by-jurisdiction basis. In an industry where regulatory timelines can determine commercial success, we offer agile responses and direct engagement with health regulators, without compromising the technical rigor the sector demands.